Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Guiqiang Wang and Xianxiang Chen.
Guiqiang Wang
Connection Strength
0.519
Xianxiang Chen
  1. Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial. Int Immunopharmacol. 2021 Aug; 97:107702.
    View in: PubMed
    Score: 0.235
  2. Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size. Biomed Pharmacother. 2021 Jan; 133:110825.
    View in: PubMed
    Score: 0.226
  3. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. J Autoimmun. 2021 03; 118:102596.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.